Suchergebnisse - "Xu, Zhanxue"

PubPharm (29)

1

TRAF6 enhances PD-L1 expression through YAP1-TFCP2 signaling in melanoma

enthalten in: Cancer letters | 2024

von Wang, L. | Liu, X. | Han, Y. | +10

2

Dual-Targeting Nanovesicles Carrying CSF1/CD47 Identified from Single-Cell Transcriptomics of Innate Immune Cells in Heart Transplant for Alleviating Acute Rejection

enthalten in: Advanced healthcare materials | 2024

von Xu, Z. | Mao, X. | Lu, X. | +13

3

Dual‐Targeting Nanovesicles Carrying CSF1/CD47 Identified from Single‐Cell Transcriptomics of Innate Immune Cells in Heart Transplant for Alleviating Acute Rejection

enthalten in: Advanced Healthcare Materials | 2024

von Xu, Z. | Mao, X. | Lu, X. | +13

4

ATAD1 inhibits hepatitis C virus infection by removing the viral TA-protein NS5B from mitochondria

enthalten in: EMBO reports | 2023

von Zhou, Q. | Yang, Y. | Xu, Z. | +12

5

Engineered small extracellular vesicles as a FGL1/PD-L1 dual-targeting delivery system for alleviating immune rejection

enthalten in: bioRxiv.org | 2023

von Tsai, H. | Wu, Y. | Liu, X. | +18

6

Plant exosomes fused with engineered mesenchymal stem cell-derived nanovesicles for synergistic therapy of autoimmune skin disorders

enthalten in: Journal of extracellular vesicles | 2023

von Huang, R. | Jia, B. | Su, D. | +7

7

NF45/NF90-mediated rDNA transcription provides a novel target for immunosuppressant development

enthalten in: bioRxiv.org | 2023

von Tsai, H. | Zeng, X. | Liu, L. | +15

8

Fe3+-binding transferrin nanovesicles encapsulating sorafenib induce ferroptosis in hepatocellular carcinoma

enthalten in: Biomaterials research | 2023

von Xiao, Y. | Xu, Z. | Cheng, Y. | +11

9

$ Fe^{3+} $-binding transferrin nanovesicles encapsulating sorafenib induce ferroptosis in hepatocellular carcinoma

enthalten in: Biomaterials Research | 2023

von Xiao, Y. | Xu, Z. | Cheng, Y. | +11

10

$ Fe^{3+} $-binding transferrin nanovesicles encapsulating sorafenib induce ferroptosis in hepatocellular carcinoma

enthalten in: Biomaterials Research | 2023

von Xiao, Y. | Xu, Z. | Cheng, Y. | +11